大葉大學圖書館 |

Cancer biomarkers in body fluids[electronic resource] :principles /

紀錄類型:	書目-電子資源 : Monograph/item
杜威分類號:	616.9940756
書名/作者:	Cancer biomarkers in body fluids : principles // by Gabriel D. Dakubo.
作者:	Dakubo, Gabriel D.
出版者:	Cham : : Springer International Publishing :, 2016.
面頁冊數:	xvi, 299 p. : : ill., digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Cancer - Molecular diagnosis.
標題:	Cancer - Genetic aspects.
標題:	Biochemical markers.
標題:	Biomedicine.
標題:	Human Genetics.
標題:	Oncology.
標題:	Cancer Research.
ISBN:	9783319015804
ISBN:	9783319015798
摘要、提要註:	The molecular and genetic signatures of cancer are represented in the peripheral circulation and other body fluids, giving rise to the "liquid biopsy" concept. This new paradigm of molecular profiling of cancer cells offers several advantages over traditional tissue biopsy. It is convenient, noninvasive, conforms to current clinical practice, enables real time disease monitoring and the study of tumor evolution, can easily be sampled multiple times, and this sample is more representative of the heterogeneous cancer cells than biopsy sampling. Indeed, all aspects of cancer molecular genetic information, stemming from DNA (both nuclear and mitochondria), RNA (coding and noncoding), peptides and proteins, metabolites and lipids are present in body fluids as free, cell surface bound or enclosed in membrane vesicles, and are being harnessed for disease management. Additionally, circulating tumor, and tumor stem cells provide prognostic information, and also enable the study of the intricate molecular processes associated with metastasis and drug resistance. This treatise deals with the general principles of the molecular pathology of cancer, and its associated imprints in circulation. The transitional process from discovery, prototype development, translational research, to product development can be complex and costly. The critical path to biomarker development and qualification for successful use in drug development is detailed herein as well. This book is of interest to Cancer Researchers, Oncologists, Clinicians, Surgeons, Medical Students, Nurses, Diagnostic Laboratories, and Pharmaceutical Industries.
電子資源:	http://dx.doi.org/10.1007/978-3-319-01580-4

Cancer biomarkers in body fluids[electronic resource] :principles /
Dakubo, Gabriel D.

Cancer biomarkers in body fluidsprinciples /[electronic resource] :by Gabriel D. Dakubo. - Cham :Springer International Publishing :2016. - xvi, 299 p. :ill., digital ;24 cm.

The molecular and genetic signatures of cancer are represented in the peripheral circulation and other body fluids, giving rise to the "liquid biopsy" concept. This new paradigm of molecular profiling of cancer cells offers several advantages over traditional tissue biopsy. It is convenient, noninvasive, conforms to current clinical practice, enables real time disease monitoring and the study of tumor evolution, can easily be sampled multiple times, and this sample is more representative of the heterogeneous cancer cells than biopsy sampling. Indeed, all aspects of cancer molecular genetic information, stemming from DNA (both nuclear and mitochondria), RNA (coding and noncoding), peptides and proteins, metabolites and lipids are present in body fluids as free, cell surface bound or enclosed in membrane vesicles, and are being harnessed for disease management. Additionally, circulating tumor, and tumor stem cells provide prognostic information, and also enable the study of the intricate molecular processes associated with metastasis and drug resistance. This treatise deals with the general principles of the molecular pathology of cancer, and its associated imprints in circulation. The transitional process from discovery, prototype development, translational research, to product development can be complex and costly. The critical path to biomarker development and qualification for successful use in drug development is detailed herein as well. This book is of interest to Cancer Researchers, Oncologists, Clinicians, Surgeons, Medical Students, Nurses, Diagnostic Laboratories, and Pharmaceutical Industries.

ISBN: 9783319015804

Standard No.: 10.1007/978-3-319-01580-4doiSubjects--Topical Terms:

488784
Cancer
--Molecular diagnosis.

LC Class. No.: RC270

Dewey Class. No.: 616.9940756

Cancer biomarkers in body fluids[electronic resource] :principles /
LDR:02545nmm a2200301 a 4500 001 466075
003 DE-He213
005 20160901122758.0
006 m d
007 cr nn 008maaau
008 170415s2016 gw s 0 eng d
020 $a 9783319015804 $q (electronic bk.)
020 $a 9783319015798 $q (paper)
024 7 $a 10.1007/978-3-319-01580-4 $2 doi
035 $a 978-3-319-01580-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC270
072 7 $a MFN $2 bicssc
072 7 $a MED107000 $2 bisacsh
082 0 4 $a 616.9940756 $2 23
090 $a RC270 $b .D135 2016
100 1 $a Dakubo, Gabriel D. $3 670645
245 1 0 $a Cancer biomarkers in body fluids $h [electronic resource] : $b principles / $c by Gabriel D. Dakubo.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a xvi, 299 p. : $b ill., digital ; $c 24 cm.
520 $a The molecular and genetic signatures of cancer are represented in the peripheral circulation and other body fluids, giving rise to the "liquid biopsy" concept. This new paradigm of molecular profiling of cancer cells offers several advantages over traditional tissue biopsy. It is convenient, noninvasive, conforms to current clinical practice, enables real time disease monitoring and the study of tumor evolution, can easily be sampled multiple times, and this sample is more representative of the heterogeneous cancer cells than biopsy sampling. Indeed, all aspects of cancer molecular genetic information, stemming from DNA (both nuclear and mitochondria), RNA (coding and noncoding), peptides and proteins, metabolites and lipids are present in body fluids as free, cell surface bound or enclosed in membrane vesicles, and are being harnessed for disease management. Additionally, circulating tumor, and tumor stem cells provide prognostic information, and also enable the study of the intricate molecular processes associated with metastasis and drug resistance. This treatise deals with the general principles of the molecular pathology of cancer, and its associated imprints in circulation. The transitional process from discovery, prototype development, translational research, to product development can be complex and costly. The critical path to biomarker development and qualification for successful use in drug development is detailed herein as well. This book is of interest to Cancer Researchers, Oncologists, Clinicians, Surgeons, Medical Students, Nurses, Diagnostic Laboratories, and Pharmaceutical Industries.
650 0 $a Cancer $x Molecular diagnosis. $3 488784
650 0 $a Cancer $x Genetic aspects. $3 336980
650 0 $a Biochemical markers. $3 431086
650 1 4 $a Biomedicine. $3 463454
650 2 4 $a Human Genetics. $3 464334
650 2 4 $a Oncology. $3 205017
650 2 4 $a Cancer Research. $3 463530
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-01580-4
950 $a Biomedical and Life Sciences (Springer-11642)